ARCHIVES

FDA Approves Erbitux for Head & Neck Cancer.

This article is from The Cancer Letter archive.

Vol. 32 No. 08 | March 3, 2006

Download PDF Visit The Full Archive

Related Articles

Patient Groups Are Focus of New Alliances In a Shift of Cancer Advocacy Agenda

May 31, 1996

Progress Reported On Zinder Recommendations for Virus Program

July 4, 1975

Undeterred By Randomized Trial Results, AUA Calls For Baseline PSA At Age 40.

May 1, 2009

NTP Board Plans Peer Review Of Bioassay Reports

April 11, 1980

Centocor Withdraws Yondelis After FDA Calls for New Study

April 29, 2011

FDA Approvals: Cobas HPV Test Approved For Primary Cervical Screening

April 25, 2014